Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Current Problems in Cancer. Case Reports|March 16, 2026
Breast-implant associated unicentric castleman disease: a case reportSaishravan Shyamsundar, Mateo Sarmiento Bustamante, Larissa Borys, et al.
Cancer|April 27, 2012
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomasRajni Sinha, Jonathan L Kaufman, Hanna Jean Khoury, et al.
Transfusion|April 16, 2011
Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kineticsJie Li, Ellie Hamilton, Louette Vaughn, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2013
Vinorelbine, paclitaxel, etoposide, cisplatin, and cytarabine (VTEPA) is an effective second salvage therapy for relapsed/refractory Hodgkin lymphomaRajni Sinha, Pareen J Shenoy, Nassoma King, et al.
Haematologica|January 11, 2024
Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman diseaseMateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin LymphomaJonathon B Cohen, Silvana Bucur, Elliott F Winton, et al.
Cancers|August 23, 2020
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell LymphomaAuris Huen, Bradley M Haverkos, Jasmine Zain, et al.
Blood|March 8, 2012
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphomaSteven M Horwitz, Youn H Kim, Francine Foss, et al.
British Journal of Haematology|May 22, 2023
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphomaRobert Stuver, Steven M Horwitz, Ranjana H Advani, et al.
Leukemia & Lymphoma|May 16, 2014
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphomaLoretta J Nastoupil, Pareen J Shenoy, Alex Ambinder, et al.
Pageof 8